Sign inJoin waitlistJoin the waitlist

Horng H. Chen

Chair, Division of Circulatory Failure, Department of Cardiovascular Medicine · Mayo Clinic

Credentials: · ·

History

Mayo Clinic
Present

Research

Diuretic strategies in patients with acute decompensated heart failure
New England Journal of Medicine · 2011 · 1,263 citations
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial
JAMA · 2013 · 988 citations
Ultrafiltration in decompensated heart failure with cardiorenal syndrome
New England Journal of Medicine · 2012 · 720 citations

John Burnett
88 papers
Margaret Redfield
44 papers
AC
Alessandro Cataliotti
28 papers · 1 as a resident
JS
John Schirger
23 papers · 11 as a resident
Paul McKie
21 papers · 10 as a resident
Gary Felker
17 papers
SW
Siu-Hin Wan
13 papers · 8 as a resident
Adrian Hernandez
11 papers
Barry Borlaug
11 papers
EB
Eugene Braunwald
11 papers
Fadi Adel
11 papers · 11 as a resident
GB
Guido Boerrigter
11 papers · 4 as a resident

Grants

Human Cardiorenal Syndrome
National Heart, Lung, and Blood Institute · R01
Contact PI · $5.5M · Mayo Clinic Rochester
2006–2027
Preclinical Diastolic Dysfunction in Type 2 Diabetes
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.8M · Mayo Clinic Rochester
2018–2023
Cardiovascular Peptides and Myocardial Infarction
National Heart, Lung, and Blood Institute · R01
PI · $2.7M · Mayo Clinic Rochester
2006–2017
Protein Therapeutics to Prevent Heart Failure Post Myocardial Infarction
National Heart, Lung, and Blood Institute · P20
PI · $1.5M · Mayo Clinic Rochester
2010–2013

Clinical trials

PDD in Type 2 Diabetes w/wo Diastolic Dysfunction
Principal investigator · Completed · Phase 2
Mayo Clinic
2018–2025
Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)
Principal investigator · Completed · Phase 1, Phase 2
Mayo Clinic
2014–2019
Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)
Principal investigator · Completed · Phase 1, Phase 2
Mayo Clinic
2014–2019
CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function
Principal investigator · Completed · Phase 1
Mayo Clinic
2013–2018